TempraMed to Showcase VIVI Cap Smart — a Connected Digital Health Device — at MEDICA 2025

Sammamish, WA — November 2025 — TempraMed, a medical technology innovator protecting temperature-sensitive injectable medications, will showcase its soon-to-be-marketed VIVI Cap Smart at MEDICA 2025 (November 17-20, Düsseldorf, Germany).

The VIVI Cap Smart is a connected digital health device combining TempraMed’s patented thermal insulation technology with smart functionality that tracks and records injection events for insulin, GLP-1, and other injectables. Designed to improve medication safety and adherence, the device syncs with a mobile app for real-time insights and data sharing between patients and healthcare providers.

TempraMed will also present a live talk titled “A Connected Approach to Safe and Timely Insulin Use” on Thursday, November 20 at 13:45 in Hall 12 D35, highlighting how connected devices enhance medication safety and adherence.

“The VIVI Cap Smart bridges medical device engineering and digital health innovation,” said Ron Nagar, CEO of TempraMed. “We’re proud to demonstrate how connected devices can empower patients to manage their treatments with confidence and precision.”

TempraMed will also display its VIVI Epi for epinephrine auto-injectors and its classic VIVI Cap temperature-shielding solutions at the Medica Startup Park Booth 12D19.

Visit www.tempramed.com or meet the team at MEDICA 2025 Startup Park Booth 12D19, to explore how TempraMed is redefining medication protection through digital health and connected care.

About TempraMed

TempraMed is a global leader in innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, TempraMed develops patented, FDA-registered, space-grade thermal insulation hassle-free devices that work 24/7 for years without charging or external power. With a proven product line including VIVI Cap and VIVI Epi, and a smart technology platform on the horizon, TempraMed enables patients and healthcare providers to confidently manage temperature-sensitive medications anywhere, anytime. With operations in North America, Europe, and Asia, TempraMed is advancing the future of medication protection and adherence.

 

Media Contact:

Brenda Zeitlin

VP Marketing, TempraMed

brenda@tempramed.com

Exhibitor Data Sheet